Skip to main content

Find Clinical Trials

Home
Conditions
Orthomyxoviridae Infections

Clinical trial condition

Orthomyxoviridae Infections

Explore clinical trials studying Orthomyxoviridae Infections. Study availability and eligibility vary by location and protocol.

1,811 public trials 85 recruiting studies

Refine in advanced search Browse all conditions

Orthomyxoviridae Infections trial results

Completed

Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine for the Elderly

NCT00938392

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Tallinn, Estonia

GSK Investigational Site Tartu, Estonia

GSK Investigational Site Bratislava, Slovakia

GSK Investigational Site Bratislava, Slovakia

View Trial Details

Completed

Immunogenicity and Safety of Vaccine GSK2340272A (H1N1) and GSK Biologicals Fluarix™ Vaccine When Co-administered in Elderly

NCT00968890

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Eskilstuna, Sweden

GSK Investigational Site Örebro, Sweden

View Trial Details

Completed

Immunogenicity and Safety of GSK Biologicals' (Pre-) Pandemic Influenza Candidate Vaccine

NCT00742885

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Fukuoka, Japan

GSK Investigational Site Tokyo, Japan

View Trial Details

Completed

A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix™ / Influsplit SSW® 2008/2009 in Adults

NCT00706563

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Dresden, Saxony, Germany

GSK Investigational Site Dresden, Saxony, Germany

GSK Investigational Site Dresden, Saxony, Germany

GSK Investigational Site Dresden, Saxony, Germany

View Trial Details

Completed

Study to Evaluate the Safety and Immune Response of Two-Doses of Candidate Influenza Vaccine GSK 1557484A in Adults

NCT00510874

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Huntsville, Alabama, United States

GSK Investigational Site Anaheim, California, United States

GSK Investigational Site Miami, Florida, United States

GSK Investigational Site Stockbridge, Georgia, United States

View Trial Details

Completed

Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1)

NCT00971425

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Rednitzhembach, Bavaria, Germany

GSK Investigational Site Mainz, Rhineland-Palatinate, Germany

GSK Investigational Site Freital, Saxony, Germany

GSK Investigational Site Berlin, Germany

View Trial Details

Completed

Clinical Study in Children, 6 Months to 3 Years of Age, to Assess Two Dose Levels of an Experimental Flu Vaccine, Using a Licensed Influenza Virus Vaccine, Vaxigrip® as the Control

NCT00778895

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Calgary, Alberta, Canada

GSK Investigational Site Langley, British Columbia, Canada

GSK Investigational Site Winnipeg, Manitoba, Canada

GSK Investigational Site Mount Pearl, Newfoundland and Labrador, Canada

View all 18 locations

View Trial Details

Completed

Safety and Immunogenocity Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Japanese Children

NCT01001169

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Tokyo, Japan

View Trial Details

Completed

Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children Aged 10 to Less Than 18 Years

NCT01035749

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Tartu, Estonia

GSK Investigational Site Cífer, Slovakia

GSK Investigational Site Dolný Kubín, Slovakia

GSK Investigational Site Dunajská Streda, Slovakia

View Trial Details

Completed

Evaluation of Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Years and Older

NCT00760617

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Güglingen, Baden-Wurttemberg, Germany

GSK Investigational Site Mannheim, Baden-Wurttemberg, Germany

GSK Investigational Site Rudersberg, Baden-Wurttemberg, Germany

GSK Investigational Site Weinheim, Baden-Wurttemberg, Germany

View all 25 locations

View Trial Details